Brief: Xintela Submits Manufacturing License Application
21/12/2020 07:34
Dec 21 (Reuters) - Xintela AB XINT.ST :
* XINTELA SUBMITS MANUFACTURING LICENSE APPLICATION
* SUBMITTED ITS APPLICATION TO SWEDISH MEDICAL PRODUCTS
AGENCY FOR
A LICENSE TO PRODUCE CELL THERAPY PRODUCTS,
Source text for Eikon: ID:nBQN55PHdz
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects